Pulse Biosciences, Inc. (PLSE) Analyst Estimates Annual - Discounting Cash Flows
PLSE
Pulse Biosciences, Inc.
PLSE (NASDAQ)
Period Ending: 2030
12-31
2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2022
12-30
2021
12-30
Number of Analysts 1 1 1 2 2 1 1 1 1
Estimated Revenue
Low 152.4 80.52 35.19 11 2.5 0.129 0.687 0.709 1.45
Average 177.5 93.8 41 12.5 3.23 0.15 0.8 0.709 1.45
High 202.6 107.1 46.79 14 3.94 0.171 0.913 0.709 1.45
Estimated EBITDA
Low -40.52 -21.41 -9.36 -2.8 -0.789 -0.034 -0.183 0.142 0.289
Average -35.5 -18.76 -8.2 -2.5 -0.645 -0.03 -0.16 0.142 0.289
High -30.47 -16.1 -7.04 -2.2 -0.499 -0.026 -0.137 0.142 0.289
Estimated EBIT
Low -40.52 -21.41 -9.36 -2.8 -0.789 -0.034 -0.183 0.142 0.289
Average -35.5 -18.76 -8.2 -2.5 -0.645 -0.03 -0.16 0.142 0.289
High -30.47 -16.1 -7.04 -2.2 -0.499 -0.026 -0.137 0.142 0.289
Estimated Net Income
Low 21.44 -24.73 -63.02 -102.1 -94.14 -81.77 -75.79 -102.2 -132.6
Average 26.28 -20.89 -53.23 -100.3 -92.26 -72.78 -64.03 -102.2 -132.6
High 31.11 -17.05 -43.44 -70.38 -64.88 -56.36 -52.24 -102.2 -132.6
Estimated SGA Expenses
Low 4,707 2,487 1,087 339.8 77.12 3.98 21.21 9.07 18.5
Average 5,484 2,898 1,267 386.2 99.63 4.63 24.72 9.07 18.5
High 6,259 3,307 1,446 432.5 121.8 5.29 28.21 9.07 18.5
Estimated EPS
Low 0.318 -0.367 -0.935 -1.52 -1.4 -1.21 -1.12 -1.75 -2.27
Average 0.39 -0.31 -0.79 -1.28 -1.18 -1.02 -0.95 -1.75 -2.27
High 0.462 -0.253 -0.645 -1.04 -0.963 -0.836 -0.775 -1.75 -2.27
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program